Logo image of SNW.DE

SANOFI (SNW.DE) Stock Fundamental Analysis

Europe - FRA:SNW - FR0000120578 - Common Stock

87.71 EUR
-0.47 (-0.53%)
Last: 10/31/2025, 7:00:00 PM
Fundamental Rating

5

Overall SNW gets a fundamental rating of 5 out of 10. We evaluated SNW against 52 industry peers in the Pharmaceuticals industry. SNW has an excellent profitability rating, but there are some minor concerns on its financial health. SNW is not valued too expensively and it also shows a decent growth rate. SNW also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SNW was profitable.
SNW had a positive operating cash flow in the past year.
SNW had positive earnings in each of the past 5 years.
In the past 5 years SNW always reported a positive cash flow from operatings.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

SNW has a better Return On Assets (11.05%) than 73.08% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, SNW is in the better half of the industry, outperforming 63.46% of the companies in the same industry.
SNW has a Return On Invested Capital of 13.84%. This is in the better half of the industry: SNW outperforms 67.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SNW is significantly below the industry average of 15.23%.
The last Return On Invested Capital (13.84%) for SNW is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SNW's Profit Margin of 20.35% is fine compared to the rest of the industry. SNW outperforms 75.00% of its industry peers.
SNW's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 23.59%, SNW perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
In the last couple of years the Operating Margin of SNW has grown nicely.
SNW has a Gross Margin (71.70%) which is in line with its industry peers.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNW is creating some value.
The number of shares outstanding for SNW remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SNW has about the same amount of shares outstanding.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of SNW is 2.21, which is a good value as it means it would take SNW, 2.21 years of fcf income to pay off all of its debts.
SNW has a better Debt to FCF ratio (2.21) than 78.85% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SNW is not too dependend on debt financing.
SNW's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. SNW outperforms 71.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.79
WACC7.72%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

SNW has a Current Ratio of 1.27. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SNW (1.27) is comparable to the rest of the industry.
A Quick Ratio of 0.94 indicates that SNW may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, SNW perfoms like the industry average, outperforming 51.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

SNW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.36%.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
SNW shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-23.36%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-48.79%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.85%

3.2 Future

Based on estimates for the next years, SNW will show a small growth in Earnings Per Share. The EPS will grow by 6.84% on average per year.
Based on estimates for the next years, SNW will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.26, SNW is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 63.46% of the companies listed in the same industry.
SNW's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.10.
With a Price/Forward Earnings ratio of 10.11, the valuation of SNW can be described as very reasonable.
SNW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SNW is cheaper than 78.85% of the companies in the same industry.
SNW is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.26
Fwd PE 10.11
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SNW's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.22
EV/EBITDA 11.32
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.46
PEG (5Y)2.8
EPS Next 2Y6.3%
EPS Next 3Y6.57%

8

5. Dividend

5.1 Amount

SNW has a Yearly Dividend Yield of 4.53%, which is a nice return.
SNW's Dividend Yield is rather good when compared to the industry average which is at 2.98. SNW pays more dividend than 84.62% of the companies in the same industry.
SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 4.53%

5.2 History

The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

SANOFI

FRA:SNW (10/31/2025, 7:00:00 PM)

87.71

-0.47 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap213.75B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target109.57 (24.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.53%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.45%
PT rev (3m)-2.02%
EPS NQ rev (1m)-3.87%
EPS NQ rev (3m)-9.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-1.51%
Revenue NQ rev (3m)-3.33%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.93%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 10.11
P/S 3.15
P/FCF 21.22
P/OCF 18.78
P/B 3.05
P/tB 23
EV/EBITDA 11.32
EPS(TTM)6.15
EY7.01%
EPS(NY)8.68
Fwd EY9.89%
FCF(TTM)4.13
FCFY4.71%
OCF(TTM)4.67
OCFY5.32%
SpS27.86
BVpS28.73
TBVpS3.81
PEG (NY)3.46
PEG (5Y)2.8
Graham Number63.05
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.72%
ROIC/WACC1.79
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.36%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-48.79%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.84%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.85%
Revenue Next Year-0.42%
Revenue Next 2Y3.06%
Revenue Next 3Y4.26%
Revenue Next 5Y4.46%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.93%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SNW.DE) has a profitability rating of 7 / 10.


What is the financial health of SANOFI (SNW.DE) stock?

The financial health rating of SANOFI (SNW.DE) is 4 / 10.


What is the expected EPS growth for SANOFI (SNW.DE) stock?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 4.12% in the next year.